About Us
Nanophysics & Beyond
Curadigm
The Management
Our Commitments
Healthcare Professionals
Scientific Publications
Patients
Patient Engagement
Shareholders
Corporate Presentation
Financial Calendar
Regulated Information
Annual General Meetings
Shareholder Corner
Press Releases
Nanotalks
NBTXR3 Development
Head & Neck Cancer
R&D Day
Congresses
& Events
Our Expert Videos
From Curie to Nano
Contact & Newsletter
Medical Device Vigilance – Pharmacovigilance
Medical Information
Join Us
Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Continuer
Rester sur la page
Scientific Clinical | Nanobiotix announces new results from pre-clinical immuno-oncology study at SITC 2019
Financial | Nanobiotix announces third quarter 2019 revenue
25 October 2019
Corporate | Nanobiotix receives the 2019 Prix Galien award for first-in-class Hensify
16 December 2019
Scientific Clinical | Nanobiotix announces new results from pre-clinical immuno-oncology study at SITC 2019
Published by
Julie Ficheux
on
12 November 2019
No translations available for this page
